Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully

NCT06774872 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

408

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Doravirine 100Mg Tab and Lamivudine 300 Mg Tab
DRUG: Dolutegravir 50mg Tab and Lamivudine 300 Mg Tab

Sponsor

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

Collaborators

[object Object]
[object Object]